Tracheal intubation: Optimal conditions, vocal cord damage, and allergy;Intubation trachéale: Conditions optimales, lésions laryngées et allergie

Canadian Journal of Anesthesia

Volumn 55, Issue 10, 2008, Pages 663-669

  Donati, François ^a   Plaud, Benoît ^b  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b CHU CÔTE DE NACRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; CHLORHEXIDINE; CISATRACURIUM; HYPNOTIC AGENT; IMMUNOGLOBULIN E ANTIBODY; LIDOCAINE; NEUROMUSCULAR BLOCKING AGENT; OPIATE; PHOLCODINE; ROCURONIUM; SUXAMETHONIUM;

ANAPHYLAXIS; CANADA; DRUG HYPERSENSITIVITY; EDITORIAL; ENDOTRACHEAL INTUBATION; FOOD AND DRUG ADMINISTRATION; FRANCE; HOARSENESS; HUMAN; PRIORITY JOURNAL; SORE THROAT; UNITED KINGDOM; UNITED STATES; VOCAL CORD DISORDER;

ANAPHYLAXIS; HOARSENESS; HUMANS; INTUBATION, INTRATRACHEAL; NEUROMUSCULAR BLOCKING AGENTS; PHARYNGITIS; POSTOPERATIVE COMPLICATIONS; VOCAL CORDS;

EID: 56049102160     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03017741     Document Type: Editorial

References (18)

1. Viby-Mogensen J, Engbaek J, Eriksson LI, et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996; 40: 59-74.
2. th International Neuromuscular Meeting. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand 2007; 51: 789-808.
3. Bouvet L, Stoian A, Jacquot-Laperriere S, Allaouchiche B, Chassard D, Boselli E. laryngeal injuries and intubating conditions with or without muscular relaxation: an equivalence study. Can J Anesth 2008; 55: 674-84.
4. Warner MA, Warner ME, Weber JG. Clinical significance of pulmonary aspiration during the postoperative period. Anesthesiology 1993; 78: 56-62.
5. Mencke T, Echternach M, Kleinschmidt S, et al. laryngeal morbidity and quality of tracheal intubation: a randomized controlled trial. Anesthesiology 2003; 98: 1049-56.
6. Donati F. The right dose of succinylcholine. Anesthesiology 2003; 99: 1037-8.
7. Domino KB, Posner KL, Caplan RA, Cheney FW. Airway injury during anesthesia: a closed claim analysis. Anesthesiology 1999; 91: 1703-11.
8. Mencke T, Echternach M, Plinkert PK, et al. Does the timing of tracheal intubation based on neuromuscular monitoring decrease laryngeal injury? A randomized, prospective, controlled trial. Anesth Analg 2006; 102: 306-12.
9. Mencke T, Knoll H, Schreiber JU, et al. Rocuronium is not associated with more vocal cord injuries than succinylcholine after rapid-sequence induction: a randomized, prospective, controlled trial. Anesth Analg 2006; 102: 943-9.
10. Barclay K, Eggers K, Asai T. low-dose rocuronium improves conditions for tracheal intubation after induction of anaesthesia with propofol and alfentanil. Br J Anaesth 1997; 78: 92-4.
11. Naguib M, Kopman AF, Ensor JE. Neuromuscular monitoring and postoperative residual curarization: a meta-analysis. Br J Anaesth 2007; 98: 302-16.
12. Laxenaire MC, Mertes PM; Groupe d'Études de Réactions Anaphylactoïdes Peranesthésiques. Anaphylaxis during anaesthesia. Results of a two-year survey in France. Br J Anaesth 2001; 87: 549-58.
13. Mertes PM, Laxenaire MC, Alla F; Groupe d'Études de Réactions Anaphylactoïdes Peranesthésiques. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003; 99: 536-45.
14. Malinovsky JM, Decagny S, Wessel F, Guilloux L, Mertes PM. Systematic follow-up increases incidence of anaphylaxis during adverse reactions in anesthetized patients. Acta Anaesthesiol Scand 2008; 52: 175-81.
15. Laake JH, Rottingen JA. Rocuronium and anaphylaxis - a statistical challenge. Acta Anaesthesiol Scand 2001; 45: 1196-203.
16. Garvey LH, Roed-Petersen J, Menne T, Husum B. Danish Anaesthesia Allergy Centre - preliminary results. Acta Anaesthesiol Scand 2001; 45: 1204-9.
17. Bhananker SM, O'Donnell JT, Salemi JR, Bishop MJ. The risk of anaphylactic reactions to rocuronium in the United States is comparable to that of vecuronium: an analysis of Food and Drug Administration reporting of adverse events. Anesth Analg 2005; 101: 819-22.
18. Florvaag E, Johansson SG, Oman H, et al. Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA analphylaxis in Norway and Sweden, respectively. Acta Anaesthesiol Scand 2005; 437-44.